Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain - PubMed (original) (raw)
Comparative Study
Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain
Ajay D Wasan et al. Clin J Pain. 2007 May.
Abstract
Objective: To investigate the role of psychiatric history and psychologic adjustment on aberrant drug-related behavior among patients prescribed opioids for noncancer pain.
Methods: Two hundred twenty-eight patients prescribed opioids for chronic pain were classified as either high or low on psychiatric morbidity on the basis of their responses on the psychiatric subscale of the Prescription Drug Use Questionnaire (PDUQ). They also completed the Brief Pain Inventory (BPI), Screener and Opioid Assessment for Pain Patients (SOAPP), and the Current Medication Misuse Measure (COMM). Patients were followed for 5 months and submitted a urine toxicology screen, and their treating physician completed the Prescription Opioid Therapy Questionnaire (POTQ). On the basis of the results from the SOAPP, COMM, POTQ, and urine screens, patients were classified as positive or negative on the Drug Misuse Index (DMI).
Results: One hundred and three (N=103) of the patients (45%) were classified in the low psychiatric group (Low Psych) whereas 55% (N=125) were classified in the high psychiatric morbidity group (High Psych). High Psych patients were significantly younger than Low Psych patients and had been taking opioids longer (P<0.05). The High Psych group showed significantly higher SOAPP and COMM scores than the Low Psych patients (P<0.001), had a greater frequency of abnormal urine toxicology screens (P<0.01), and significantly higher scores on the DMI (P<0.001). A consistent association was found between psychiatric morbidity and prescription opioid misuse in chronic pain patients.
Discussion: Psychiatric factors, such as a history of mood disorder, psychologic problems, and psychosocial stressors, may place patients at risk for misuse of prescription opioids. Future studies to elucidate the risk of medication misuse and aberrant drug behavior among this patient population are needed.
Similar articles
- Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP).
Akbik H, Butler SF, Budman SH, Fernandez K, Katz NP, Jamison RN. Akbik H, et al. J Pain Symptom Manage. 2006 Sep;32(3):287-93. doi: 10.1016/j.jpainsymman.2006.03.010. J Pain Symptom Manage. 2006. PMID: 16939853 Clinical Trial. - Validation of a screener and opioid assessment measure for patients with chronic pain.
Butler SF, Budman SH, Fernandez K, Jamison RN. Butler SF, et al. Pain. 2004 Nov;112(1-2):65-75. doi: 10.1016/j.pain.2004.07.026. Pain. 2004. PMID: 15494186 - Do pain patients at high risk for substance misuse experience more pain? A longitudinal outcomes study.
Jamison RN, Link CL, Marceau LD. Jamison RN, et al. Pain Med. 2009 Sep;10(6):1084-94. doi: 10.1111/j.1526-4637.2009.00679.x. Epub 2009 Aug 7. Pain Med. 2009. PMID: 19671087 - Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P. Pergolizzi J, et al. Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
Cited by
- Patient Experiences and Clinical Outcomes in a Multidisciplinary Perioperative Transitional Pain Service.
Manoharan D, Xie A, Hsu YJ, Flynn HK, Beiene Z, Giagtzis A, Shechter R, McDonald E, Marsteller J, Hanna M, Speed TJ. Manoharan D, et al. J Pers Med. 2023 Dec 26;14(1):31. doi: 10.3390/jpm14010031. J Pers Med. 2023. PMID: 38248732 Free PMC article. - [Factors influencing analgesic use patterns in patients with chronic tumor-associated pain. : A qualitative pilot study considering different groups of medications].
Zugaj MR, Züger A, Keßler J. Zugaj MR, et al. Schmerz. 2024 Dec;38(6):422-432. doi: 10.1007/s00482-023-00765-y. Epub 2023 Nov 13. Schmerz. 2024. PMID: 37955709 German. - Mindfulness-based cognitive therapy for chronic noncancer pain and prescription opioid use disorder: A qualitative pilot study of its feasibility and the perceived process of change.
Ellerbroek H, Hanssen I, Lathouwers K, Cillessen L, Dekkers S, Veldman SE, van den Heuvel SAS, Speckens AEM, Schellekens AFA. Ellerbroek H, et al. Brain Behav. 2023 Jul;13(7):e3005. doi: 10.1002/brb3.3005. Epub 2023 May 24. Brain Behav. 2023. PMID: 37226589 Free PMC article. - Opioid coping motives and pain intensity among adults with chronic low back pain: associations with mood, pain reactivity, and opioid misuse.
Rogers AH, Heggeness LF, Smit T, Zvolensky MJ. Rogers AH, et al. J Behav Med. 2023 Oct;46(5):860-870. doi: 10.1007/s10865-023-00416-8. Epub 2023 May 6. J Behav Med. 2023. PMID: 37148396 - Opioid and cannabis co-use: The role of opioid use to cope with negative affect.
Buckner JD, Scherzer CR, Rogers AH, Zvolensky MJ. Buckner JD, et al. J Subst Use Addict Treat. 2023 Feb;145:208942. doi: 10.1016/j.josat.2022.208942. Epub 2023 Jan 6. J Subst Use Addict Treat. 2023. PMID: 36880919 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical